Blueprint Medicines Corporation

Blueprint Medicines Corporationverified

BPMC

Price:

$94.15

Market Cap:

$5.98B

Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibitor for the treatment of non-advanced SM and other mast cell disorders; and Fisogatinib, an orally available and potent inhibitor for the treatment of hepatocellular carcinoma. It is also developing GAVRETO for the treatment of RET fusion-positive non-small cell lung cancer, altered solid tumors, medullary thyroid carcinoma, and other solid tumors; BLU...[Read more]

Industry

Biotechnology

IPO Date

2015-04-30

Stock Exchange

NASDAQ

Ticker

BPMC

The Enterprise Value as of November 2024 (TTM) for Blueprint Medicines Corporation (BPMC) is 6.36B

According to Blueprint Medicines Corporation’s latest financial reports and current stock price. The company's current Enterprise Value is 6.36B. This represents a change of -4.08% compared to the average of 6.63B of the last 4 quarters.

Blueprint Medicines Corporation (BPMC) Historical Enterprise Value (quarterly & annually)

How has BPMC Enterprise Value performed in the past?

The mean historical Enterprise Value of Blueprint Medicines Corporation over the last ten years is 3.01B. The current 6.36B Enterprise Value has changed 21.06% with respect to the historical average. Over the past ten years (40 quarters), BPMC's Enterprise Value was at its highest in in the June 2024 quarter at 7.55B. The Enterprise Value was at its lowest in in the June 2015 quarter at 271.71M.

Quarterly (TTM)
Annual

Average

3.01B

Median

2.52B

Minimum

208.68M

Maximum

6.29B

Blueprint Medicines Corporation (BPMC) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Blueprint Medicines Corporation Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 333.14%

Maximum Annual Enterprise Value = 6.29B

Minimum Annual Increase = -55.66%

Minimum Annual Enterprise Value = 208.68M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20236.29B129.88%
20222.74B-55.66%
20216.17B11.74%
20205.52B44.77%
20193.81B64.99%
20182.31B5.40%
20172.19B333.14%
2016506.29M57.45%
2015321.57M54.10%
2014208.68M-15.77%

Blueprint Medicines Corporation (BPMC) Average Enterprise Value

How has BPMC Enterprise Value performed in the past?

The current Enterprise Value of Blueprint Medicines Corporation (BPMC) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

5.06B

5-year avg

4.91B

10-year avg

3.01B

Blueprint Medicines Corporation (BPMC) Enterprise Value vs. Peers

How is BPMC’s Enterprise Value compared to its peers?

Blueprint Medicines Corporation’s Enterprise Value is greater than Terns Pharmaceuticals, Inc. (222.97M), greater than Amylyx Pharmaceuticals, Inc. (291.98M), greater than Acumen Pharmaceuticals, Inc. (139.19M), greater than Inozyme Pharma, Inc. (202.73M), greater than X4 Pharmaceuticals, Inc. (38.44M), greater than PTC Therapeutics, Inc. (3.21B), greater than Krystal Biotech, Inc. (5.10B), greater than Intercept Pharmaceuticals, Inc. (915.81M), less than Madrigal Pharmaceuticals, Inc. (7.46B), greater than Day One Biopharmaceuticals, Inc. (963.46M), greater than Mereo BioPharma Group plc (496.22M), greater than IVERIC bio, Inc. (5.13B), less than Karuna Therapeutics, Inc. (12.43B),

Build a custom stock screener for Blueprint Medicines Corporation (BPMC) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Blueprint Medicines Corporation using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Blueprint Medicines Corporation (BPMC) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Blueprint Medicines Corporation or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Blueprint Medicines Corporation's Enterprise Value?

What is the highest Enterprise Value for Blueprint Medicines Corporation (BPMC)?

What is the 3-year average Enterprise Value for Blueprint Medicines Corporation (BPMC)?

What is the 5-year average Enterprise Value for Blueprint Medicines Corporation (BPMC)?

How does the current Enterprise Value for Blueprint Medicines Corporation (BPMC) compare to its historical average?